Venrock Healthcare Capital Partners Iii is based out of New York. Whalewisdom has at least 1 13D filings, 54 13G filings, and 16 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-04-20. The filing was for a pooled investment fund: venture capital fund The notice included securities offered of Pooled Investment Fund Interests
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.530 FIFTH AVENUE, 22ND FLOOR
NEW YORK NY 10036
Business Phone: 212-444-4100
Current 13D/G Holdings
| Stock | Sector | Shares Held | Market Value | Rank | Source | Source Date |
|---|---|---|---|---|---|---|
| RayzeBio Inc. | 4,030,471 | 250,574,382 | 1 | 13G | 2024-02-14 | |
| Viridian Therapeutics Inc | HEALTH CARE | 5,555,568 | 121,000,271 | 2 | 13G | 2024-02-14 |
| Apogee Therapeutics Inc. | HEALTH CARE | 3,887,478 | 108,616,135 | 3 | 13D | 2023-07-28 |
| Pharvaris BV | HEALTH CARE | 3,395,606 | 95,246,748 | 4 | 13G | 2024-02-14 |
| 4D Molecular Therapeutics, Inc. | HEALTH CARE | 4,400,000 | 89,144,000 | 5 | 13G | 2024-02-14 |
| Spyre Therapeutics Inc. | HEALTH CARE | 3,734,514 | 80,366,741 | 6 | 13G | 2024-02-14 |
| KalVista Pharmaceuticals Inc | HEALTH CARE | 4,824,731 | 59,102,955 | 7 | 13G | 2024-02-14 |
| Cabaletta Bio, Inc. | HEALTH CARE | 2,563,952 | 58,201,710 | 8 | 13G | 2024-02-14 |
| ORIC Pharmaceuticals, Inc. | HEALTH CARE | 4,428,385 | 46,542,326 | 9 | 13G | 2024-02-01 |
| enGene Holdings Inc | FINANCE | 2,565,841 | 41,438,332 | 10 | 13G | 2024-02-26 |
| Enliven Therapeutics Inc | HEALTH CARE | 2,954,902 | 40,895,844 | 11 | 13G | 2024-02-14 |
| Abivax | 3,611,570 | 38,643,799 | 12 | 13G | 2024-02-14 | |
| Celcuity Inc | HEALTH CARE | 2,476,980 | 36,089,599 | 13 | 13G | 2024-02-14 |
| Ocular Therapeutix Inc | HEALTH CARE | 7,775,760 | 34,679,890 | 14 | 13G | 2023-12-28 |
| Terns Pharmaceuticals Inc | HEALTH CARE | 4,497,117 | 29,186,289 | 15 | 13G | 2024-02-14 |
| Applied Therapeutics Inc | HEALTH CARE | 7,877,817 | 26,390,687 | 16 | 13G | 2024-02-14 |
| Mersana Therapeutics Inc | HEALTH CARE | 11,328,000 | 26,280,960 | 17 | 13G | 2024-02-14 |
| Astria Therapeutics Inc | HEALTH CARE | 3,225,806 | 24,774,190 | 18 | 13G | 2024-01-02 |
| Aquestive Therapeutics Inc | HEALTH CARE | 5,555,555 | 24,333,331 | 19 | 13G | 2024-04-01 |
| Taysha Gene Therapies, Inc. | HEALTH CARE | 10,412,872 | 18,430,783 | 20 | 13G | 2024-02-14 |
| Praxis Precision Medicines, Inc. | HEALTH CARE | 823,626 | 18,350,387 | 21 | 13G | 2024-02-14 |
| Century Therapeutics Inc | HEALTH CARE | 3,405,133 | 14,165,353 | 22 | 13G | 2024-03-04 |
| Avalanche Biotechnologies Inc | HEALTH CARE | 15,564,213 | 11,719,852 | 23 | 13G | 2024-02-14 |
| Dianthus Therapeutics Inc | HEALTH CARE | 927,706 | 603,009 | 24 | 13G | 2023-09-21 |